Identification of Multiple Serine Racemase (SRR) mRNA Isoforms and Genetic Analyses of SRR and DAO in Schizophrenia and d-Serine Levels

@article{Yamada2005IdentificationOM,
  title={Identification of Multiple Serine Racemase (SRR) mRNA Isoforms and Genetic Analyses of SRR and DAO in Schizophrenia and d-Serine Levels},
  author={Kazuo Yamada and Tetsuo Ohnishi and Kenji Hashimoto and Hisako Ohba and Yoshimi Iwayama-Shigeno and Manabu Toyoshima and Akira Okuno and Hitomi Takao and Tomoko Toyota and Yoshio Minabe and Kazuhiko Nakamura and Eiji Shimizu and Masanari Itokawa and Norio Mori and Masaomi Iyo and Takeo Yoshikawa},
  journal={Biological Psychiatry},
  year={2005},
  volume={57},
  pages={1493-1503}
}

Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model.

Analysis of SRR genetic variants in humans identified a robust association with schizophrenia and demonstrates that aberrant Srr function and diminished d-serine may contribute to schizophrenia pathogenesis.

Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia

The frequency of the genotypes showed that although the 5'-G/C SRR polymorphism is obviously not a major risk factor for schizophrenia, the modest contribution of thegenotypes as a protective or vice versa disease risk factors have to be considered further.

Serine racemase binds to PICK1: potential relevance to schizophrenia

This study identifies and characterize protein interacting with C-kinase (PICK1) as a protein interactor of the D-serine synthesizing enzyme, serine racemase (SR).

Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion

Findings support a model wherein mutant DISC1 leads to SR degradation via dominant negative effects, resulting in D-serine deficiency that diminishes NMDA neurotransmission thus linking DISC 1 and NMDA pathophysiological mechanisms in mental illness.

Metabolism of the neuromodulator D-serine

An overview of the current knowledge of the metabolism of D-serine in human brain at the molecular and cellular levels, with a specific emphasis on the brain localization and regulatory pathways of D -serine, serine racemase, and D-amino acid oxidase is presented.

Metabolism of the neuromodulator d-serine

An overview of the current knowledge of the metabolism of d-serine in human brain at the molecular and cellular levels, with a specific emphasis on the brain localization and regulatory pathways of d -serine, serine racemase, and d-amino acid oxidase is presented.

Serine Racemase Knockout Mice: Neurotoxicity, Epilepsy, and Schizophrenia

The phenotypes of these SR-KO mice used as animal models of NMDAR-mediated neurotoxicity, epilepsy, and schizophrenia are reviewed and the mechanistic involvement of the SR-d-serine pathway in these neurological and psychiatric disorders is discussed.
...

References

SHOWING 1-10 OF 46 REFERENCES

A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia.

Results illustrate a genotype-phenotype correlation in schizophrenia and suggest that the longer (GT)(n) stretch may act as a risk-conferring factor that worsens chronic outcome by reducing GRIN2A levels in the brain.

Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission.

Cloning and expression of serine racemase in the brain demonstrates the conservation of D-amino acid metabolism in mammals with implications for the regulation of N-methyl-D-aspartate neurotransmission through glia-neuronal interactions.

Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia

The findings suggest that the T-200G variant causes dysfunction of NMDA receptors consisting of the NR2B subunit and may be involved in the development of schizophrenia.

The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective.

  • M. Schell
  • Biology
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • 2004
An evolutionary framework for the appearance of a glycine site in animals and the metabolic events leading to high levels of D-serine in brain is outlined and it is suggested that the properties of invertebrate NMDA receptor glycine sites are probably different from those in vertebrates.

Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.

Reduced levels of D-serine may play a role in the pathophysiology of schizophrenia, and serum D- and L-Serine levels might provide a measurable biological marker for schizophrenia.

Multiple transcriptional variants and RNA editing in C18orf1, a novel gene with LDLRA and transmembrane domains on 18p11.2.

Evidence of RNA editing in the 5'-UTR of beta 2, the first demonstration of this phenomenon in 5'-UNtranslated region (UTR), is presented.

Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder

The association of variation at G72 with schizophrenia as well as BPAD provides molecular support for the hypothesis that these two major psychiatric disorders share some of their etiologic background.